IP Library Granted Patent US 11,850,327
Granted Patent B2
US 11,850,327 · App. 17/049,281 · Granted Dec 26, 2023

Flexible hexagonal boron nitride composites for additive manufacturing applications

Inventors: Linda M. Guiney (Chicago, IL); Nikhita D. Mansukhani (Libertyville, IL); Adam E. Jakus (Chicago, IL); Ramille N. Shah (Hinsdale, IL); Mark C. Hersam (Wilmette, IL)
Assignee: Northwestern University
A61L27/446A61L27/50A61M5/14276A61N1/37512B33Y70/10B33Y80/00C08K3/38D01F1/10D01F6/625D01F6/84D01F6/92A61M2205/3633C08K2003/385
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,850,327
App. No.
17/049,281
Granted
Dec 26, 2023
Kind
B2
Abstract

Thermal management composites and scaffolds for heat-generating implantable electronic devices made from the thermal management composites are provided. The composite materials are cytocompatible, porous materials that include hexagonal boron nitride particles dispersed in an elastomeric polymer binder.

Claims (14)

1. A biocompatible device comprising:

an implantable electronic device; and

a thermally conductive, electrically insulating scaffold around at least a portion of the implantable electronic device, the scaffold comprising continuous flexible fibers of a cytocompatible composite, the cytocompatible composite comprising:

a biocompatible elastomeric polymer binder; and

hexagonal boron nitride particles dispersed in the biocompatible elastomeric polymer binder.

2. The device of claim 1 , wherein the cytocompatible composite has a hexagonal boron nitride particle content in the range from 30 vol. % to 60 vol. %.

3. The device of claim 1 , wherein the cytocompatible composite has a hexagonal boron nitride particle content in the range from 35 vol. % to 45 vol. %.

4. The device of claim 1 , wherein the cytocompatible composite has a porosity in the range from 20% to 40%.

5. The device of claim 1 , wherein the cytocompatible composite has a porosity in the range from 20% to 35%.

6. The device of claim 2 , wherein the cytocompatible composite has a porosity in the range from 20% to 40%.

7. The device of claim 6 , wherein the biocompatible elastomeric polymer binder is poly(lactic-co-glycolic acid).

8. The device of claim 7 , wherein the cytocompatible composite has a thermal conductivity of at least 1.5 W/m-K.

9. The device of claim 1 , wherein the one or more fibers have a cross-sectional diameter in the range from 50 μm to 500 μm.

10. The device of claim 9 , wherein the one or more fibers have a circular or oval cross-section.

Assignments (2)
CONFIRMATORY LICENSE Recorded Feb 13, 2025
From: NORTHWESTERN UNIVERSITY
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 070206/0230 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2021
From: GUINEY, LINDA M.; MANSUKHANI, NIKHITA D.; JAKUS, ADAM E.; SHAH, RAMILLE N.; HERSAM, MARK C.
To: NORTHWESTERN UNIVERSITY
Reel/Frame 055671/0031 →
Continuity (2)
Provisional Application 62664733 · Apr 30, 2018
Related Publication 20210038770A1 · Feb 11, 2021